| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.0079 | 0.9 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |